TY  - GEN
AU  - Giralt,S
AU  - Estey,E
AU  - Albitar,M
AU  - van Besien,K
AU  - Rondón,G
AU  - Anderlini,P
AU  - O'Brien,S
AU  - Khouri,I
AU  - Gajewski,J
AU  - Mehra,R
AU  - Claxton,D
AU  - Andersson,B
AU  - Beran,M
AU  - Przepiorka,D
AU  - Koller,C
AU  - Kornblau,S
AU  - Kørbling,M
AU  - Keating,M
AU  - Kantarjian,H
AU  - Champlin,R
TI  - Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy
SN  - 0006-4971
PY  - 1997///0710
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Cladribine
KW  - Combined Modality Therapy
KW  - Cytarabine
KW  - Feasibility Studies
KW  - Female
KW  - Filgrastim
KW  - Graft vs Host Reaction
KW  - Granulocyte Colony-Stimulating Factor
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Idarubicin
KW  - Leukemia, Myeloid
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Pilot Projects
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S
ER  -